Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-040954

Options or other derivatives

  • President and CEO acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Chin Richard President and CEO 2006-07-06 Grant or award · Option to Purchase Common Stock +250,000 250,000 D
Loading xslF345X02/rrd123145.xml…